Nivolumab with ipilimumab for untreated metastatic colorectal cancer with high microsatellite instability or mismatch repair deficiency [ID1136] Draft guidance Technology appraisal guidance 3 March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback